Domestic collaborative research of Genome-wide association study (GWAS) in predicting the therapeutic responce and adversed effect of new anticancer drugs for hepatocellular carcinoma.
Not Applicable
- Conditions
- Hepatocellular carinoma
- Registration Number
- JPRN-UMIN000008061
- Lead Sponsor
- Disease Control and Homeostasis, Graduate School of Medical Sciences, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients whom the physicians in charge judge their enrollment inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relationship between genetic factor and therapeutic response / adversed effect to new anticancer drugs for the treatment of hepatocellular carcinoma
- Secondary Outcome Measures
Name Time Method